Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis

Published:December 08, 2004DOI:https://doi.org/10.1016/j.jneuroim.2004.10.019

      Abstract

      MSRV is a retroviral element previously isolated in cell cultures from patients with multiple sclerosis. It is part of a new multi-copy endogenous retrovirus family named HERV-W and displays pro-inflammatory properties both in vitro in human PBMC cultures and in vivo in a humanized SCID mice model. In the present study, we have evaluated potential links between the pro-inflammatory properties of MSRV envelope protein and MS disease. Thus, cytokine productions mediated by the surface unit of MSRV envelope protein were evaluated in PBMC of MS patients and compared with healthy controls. Divergent reactivity to ENV-SU between MS and control PBMC was observed and was reflected by a significant increase of IFN-γ, IL-6 and IL-12p40 production by the tested MS population. Interestingly, the overproduction of IL-6 and IL-12p40 was found to correlate with disease severity (EDSS) in most patients. Altogether our data suggest that MSRV envelope protein may induce an abnormal cytokine secretion, thus contributing to the inflammatory process in MS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bar-Or A.
        • Oliveira E.M.
        • Anderson D.E.
        • Hafler D.A.
        Molecular pathogenesis of multiple sclerosis.
        J. Neuroimmunol. 1999; 100: 252-259
        • Belshaw R.
        • Pereira V.
        • Katzourakis A.
        • Talbot G.
        • Paces J.
        • Burt A.
        • Tristem M.
        Long-term reinfection of the human genome by endogenous retroviruses.
        Proc. Natl. Acad Sci. U. S. A. 2004; 101: 4894-4899
        • Chofflon M.
        • Juillard C.
        • Juillard P.
        • Gauthier G.
        • Grau G.E.
        Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.
        Eur. Cytokine Netw. 1992; 3: 523-531
        • Choi Y.
        • Kappler J.W.
        • Marrack P.
        A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus.
        Nature. 1991; 350: 203-207
        • Comabella M.
        • Balashov K.
        • Issazadeh S.
        • Smith D.
        • Weiner H.L.
        • Khoury S.J.
        Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
        J. Clin. Invest. 1998; 102: 671-678
        • Compston A.
        • Sadovnick A.D.
        Epidemiology and genetics of multiple sclerosis.
        Curr. Opin. Neurol. Neurosurg. 1992; 5: 175-181
        • Cua D.J.
        • Sherlock J.
        • Chen Y.
        • Murphy C.A.
        • Joyce B.
        • Seymour B.
        • Lucian L.
        • To W.
        • Kwan S.
        • Churakova T.
        • Zurawski S.
        • Wiekowski M.
        • Lira S.A.
        • Gorman D.
        • Kastelein R.A.
        • Sedgwick J.D.
        Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
        Nature. 2003; 421: 744-748
        • Dolei A.
        • Serra C.
        • Mameli G.
        • Pugliatti M.
        • Sechi G.
        • Cirotto M.C.
        • Rosati G.
        • Sotgiu S.
        Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
        Neurology. 2002; 58: 471-473
        • Firouzi R.
        • Rolland A.
        • Michel M.
        • Jouvin-Marche E.
        • Hauw J.J.
        • Malcus-Vocanson C.
        • Lazarini F.
        • Gebuhrer L.
        • Seigneurin J.M.
        • Touraine J.L.
        • Sanhadji K.
        • Marche P.N.
        • Perron H.
        Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model.
        J. Neurovirology. 2003; 9: 79-93
        • Frei K.
        • Fredrikson S.
        • Fontana A.
        • Link H.
        Interleukin-6 is elevated in plasma in multiple sclerosis.
        J. Neuroimmunol. 1991; 31: 147-153
        • Garson J.A.
        • Tuke P.W.
        • Giraud P.
        • Paranhos-Baccala G.
        • Perron H.
        Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.
        Lancet. 1998; 351: 33
        • Gran B.
        • Zhang G.X.
        • Yu S.
        • Li J.
        • Chen X.H.
        • Ventura E.S.
        • Kamoun M.
        • Rostami A.
        IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
        J. Immunol. 2002; 169: 7104-7110
        • Haahr S.
        • Munch M.
        The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus.
        J. Neurovirology. 2000; 6: S76-S79
        • Hintzen R.Q.
        • Polman C.H.
        Th-cell modulation in multiple sclerosis.
        Immunol. Today. 1997; 18: 507-508
        • Kohm A.P.
        • Carpentier P.A.
        • Anger H.A.
        • Miller S.D.
        Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
        J. Immunol. 2002; 169: 4712-4716
        • Komurian-Pradel F.
        • Paranhos-Baccala G.
        • Bedin F.
        • Ounanian-Paraz A.
        • Sodoyer M.
        • Ott C.
        • Rajoharison A.
        • Garcia E.
        • Mallet F.
        • Mandrand B.
        • Perron H.
        Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles.
        Virology. 1999; 260: 1-9
        • Kurtzke J.F.
        Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
        Neurology. 1983; 33: 1444-1452
        • Lafon M.
        • Jouvin-Marche E.
        • Marche P.
        • Perron H.
        Human Viral superantigens: to be or not to be transactivated?.
        Trends Immunol. 2002; 23: 238-239
        • Maimone D.
        • Gregory S.
        • Arnason B.G.
        • Reder A.T.
        Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
        J. Neuroimmunol. 1991; 32: 67-74
        • Maimone D.
        • Guazzi G.C.
        • Annunziata P.
        IL-6 detection in multiple sclerosis brain.
        J. Neurol. Sci. 1997; 146: 59-65
        • Makhlouf K.
        • Weiner H.L.
        • Khoury S.J.
        Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS.
        J. Neuroimmunol. 2001; 119: 145-149
        • Marrack P.
        • Kushnir E.
        • Kappler J.
        A maternally inherited superantigen encoded by a mammary tumour virus.
        Nature. 1991; 349: 524-526
        • Okuda Y.
        • Sakoda S.
        • Fujimura H.
        • Saeki Y.
        • Kishimoto T.
        • Yanagihara T.
        IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35–55 induced experimental autoimmune encephalomyelitis.
        J. Neuroimmunol. 1999; 101: 188-196
        • Pasare C.
        • Medzhitov R.
        Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.
        Science. 2003; 299: 1033-1036
        • Perron H.
        Microbial agents triggering endogenous retroviruses within genetic susceptibility loci, resulting in expression of superantigen and gliotoxic molecules: a plausible “ immunovirogenetic ” cascade causing multiple sclerosis?.
        Mod. Aspects Immunobiol. 2001; 1: 198-203
        • Perron H.
        • Geny C.
        • Laurent A.
        • Mouriquand C.
        • Pellat J.
        • Perret J.
        • Seigneurin J.M.
        Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles.
        Res. Virol. 1989; 140: 551-561
        • Perron H.
        • Lalande B.
        • Gratacap B.
        • Laurent A.
        • Genoulaz O.
        • Geny C.
        • Mallaret M.
        • Schuller E.
        • Stoebner P.
        • Seigneurin J.M.
        Isolation of retrovirus from patients with multiple sclerosis.
        Lancet. 1991; 337: 862-863
        • Perron H.
        • Jouvin-Marche E.
        • Michel M.
        • Ounanian-Paraz A.
        • Camelo S.
        • Dumon A.
        • Jolivet-Reynaud C.
        • Marcel F.
        • Souillet Y.
        • Borel E.
        • Gebuhrer L.
        • Santoro L.
        • Marcel S.
        • Seigneurin J.M.
        • Marche P.N.
        • Lafon M.
        Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.
        Virology. 2001; 287: 321-332
        • Petereit H.F.
        • Pukrop R.
        • Fazekas F.
        • Bamborschke S.U.
        • Ropele S.
        • Kolmel H.W.
        • Merkelbach S.
        • Japp G.
        • Jongen P.J.
        • Hartung H.P.
        • Hommes O.R.
        Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis.
        J. Neurol. Sci. 2003; 206: 209-214
        • Rep M.H.
        • Schrijver H.M.
        • van Lopik T.
        • Hintzen R.Q.
        • Roos M.T.
        • Ader H.J.
        • Polman C.H.
        • van Lier R.A.
        Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
        J. Neuroimmunol. 1999; 96: 92-100
        • Samoilova E.B.
        • Horton J.L.
        • Hilliard B.
        • Liu T.S.
        • Chen Y.
        IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
        J. Immunol. 1998; 161: 6480-6486
        • Serra C.
        • Sotgiu S.
        • Mameli G.
        • Pugliatti M.
        • Rosati G.
        • Dolei A.
        Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia.
        Neurol. Sci. 2001; 22: 171-173
        • Serra C.
        • Mameli G.
        • Arru G.
        • Sotgiu S.
        • Rosati G.
        • Dolei A.
        In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis.
        J. Neurovirology. 2003; 9: 637-643
        • Sotgiu S.
        • Serra C.
        • Mameli G.
        • Pugliatti M.
        • Rosati G.
        • Arru G.
        • Dolei A.
        Multiple sclerosis-associated retrovirus and MS prognosis: an observational study.
        Neurology. 2002; 59: 1071-1073
        • Stelmasiak Z.
        • Koziol-Montewka M.
        • Dobosz B.
        • Rejdak K.
        • Bartosik-Psujek H.
        • Mitosek-Szewczyk K.
        • Belniak-Legiec E.
        Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.
        Med. Sci. Monit. 2000; 6: 1104-1108
        • van Oosten B.W.
        • Barkhof F.
        • Scholten P.E.
        • von Blomberg B.M.
        • Ader H.J.
        • Polman C.H.
        Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.
        Arch. Neurol. 1998; 55: 793-798